Clinical trial
Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis…
NCT00265434 · University of Jena, Other · Completed
Key facts
| NCT number | NCT00265434 |
|---|---|
| Title | Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis |
| Official title | Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis |
| Lead sponsor | University of Jena, Other |
| Collaborators | PD Dr. Joachim Riethmöller, Tübingen PD Dr. Assen Koitschev, Tübingen Dr. Gerlind Schneider |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Chronic Rhinosinusitis |
| Intervention type | Drug |
| Interventions | Pulmozyme |
| Enrollment | 5 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Dec 14, 2005 |
| Last update posted | Dec 4, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: